Teva Pharmaceutical Industries Limited
TEVA
Rang in Aktien
#13240
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Aktienkurs
$41.51
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$483.77M
Veränderung (1 Tag)
-0.85%
Veränderung (1 Jahr)
107.47%
Land
IL
Handel Teva Pharmaceutical Industries Limited (TEVA)
Kategorie
Healthcare
Marktkapitalisierung von Teva Pharmaceutical Industries Limited(TEVA)
Marktkapitalisierung: $483.77M
Mit Stand October 2026 hat Teva Pharmaceutical Industries Limited eine Marktkapitalisierung von $483.77M. Das macht Teva Pharmaceutical Industries Limited laut unseren Daten zum 13240th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Teva Pharmaceutical Industries Limited von 2010 bis 2026
TEVA im Vergleich zu den Top 5 der beliebtesten stocks
